218 related articles for article (PubMed ID: 26212479)
1. Health state utility values associated with advanced gastric, oesophageal, or gastro-oesophageal junction adenocarcinoma: a systematic review.
Carter GC; King DT; Hess LM; Mitchell SA; Taipale KL; Kiiskinen U; Rajan N; Novick D; Liepa AM
J Med Econ; 2015; 18(11):954-66. PubMed ID: 26212479
[TBL] [Abstract][Full Text] [Related]
2. A systematic literature review of health state utility values in head and neck cancer.
Meregaglia M; Cairns J
Health Qual Life Outcomes; 2017 Sep; 15(1):174. PubMed ID: 28865475
[TBL] [Abstract][Full Text] [Related]
3. Systematic review of health state utility values in metastatic non-small cell lung cancer with a focus on previously treated patients.
Paracha N; Abdulla A; MacGilchrist KS
Health Qual Life Outcomes; 2018 Sep; 16(1):179. PubMed ID: 30208899
[TBL] [Abstract][Full Text] [Related]
4. EQ-5D-Derived Health State Utility Values in Hematologic Malignancies: A Catalog of 796 Utilities Based on a Systematic Review.
Golicki D; Jaśkowiak K; Wójcik A; Młyńczak K; Dobrowolska I; Gawrońska A; Basak G; Snarski E; Hołownia-Voloskova M; Jakubczyk M; Niewada M
Value Health; 2020 Jul; 23(7):953-968. PubMed ID: 32762998
[TBL] [Abstract][Full Text] [Related]
5. Mapping the cancer-specific EORTC QLQ-C30 to the preference-based EQ-5D, SF-6D, and 15D instruments.
Kontodimopoulos N; Aletras VH; Paliouras D; Niakas D
Value Health; 2009; 12(8):1151-7. PubMed ID: 19558372
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Health State Utility Measures in Patients With Head and Neck Cancer.
Noel CW; Lee DJ; Kong Q; Xu W; Simpson C; Brown D; Gilbert RW; Gullane PJ; Irish JC; Huang SH; O'Sullivan B; Goldstein DP; de Almeida JR
JAMA Otolaryngol Head Neck Surg; 2015 Aug; 141(8):696-703. PubMed ID: 26204439
[TBL] [Abstract][Full Text] [Related]
7. A structured review of health utility measures and elicitation in advanced/metastatic breast cancer.
Hao Y; Wolfram V; Cook J
Clinicoecon Outcomes Res; 2016; 8():293-303. PubMed ID: 27382319
[TBL] [Abstract][Full Text] [Related]
8. Health Utilities for Multiple Sclerosis.
Hawton A; Green C
Value Health; 2016 Jun; 19(4):460-8. PubMed ID: 27325338
[TBL] [Abstract][Full Text] [Related]
9. A systematic literature review of utility weights in wet age-related macular degeneration.
Pearson I; Rycroft C; Irving A; Ainsworth C; Wittrup-Jensen K
J Med Econ; 2013 Nov; 16(11):1307-16. PubMed ID: 24004384
[TBL] [Abstract][Full Text] [Related]
10. Health state utility values in major depressive disorder treated with pharmacological interventions: a systematic literature review.
Brockbank J; Krause T; Moss E; Pedersen AM; Mørup MF; Ahdesmäki O; Vaughan J; Brodtkorb TH
Health Qual Life Outcomes; 2021 Mar; 19(1):94. PubMed ID: 33736649
[TBL] [Abstract][Full Text] [Related]
11. A review of health utilities across conditions common in paediatric and adult populations.
Tarride JE; Burke N; Bischof M; Hopkins RB; Goeree L; Campbell K; Xie F; O'Reilly D; Goeree R
Health Qual Life Outcomes; 2010 Jan; 8():12. PubMed ID: 20105304
[TBL] [Abstract][Full Text] [Related]
12. 'Mapping' Health State Utility Values from Non-preference-Based Measures: A Systematic Literature Review in Rare Diseases.
Meregaglia M; Whittal A; Nicod E; Drummond M
Pharmacoeconomics; 2020 Jun; 38(6):557-574. PubMed ID: 32152892
[TBL] [Abstract][Full Text] [Related]
13. [Systematic review of health-related utilities in Spain: the case of mental health].
García-Pérez L; Aguiar-Ibáñez R; Pinilla-Domínguez P; Arvelo-Martín A; Linertová R; Rivero-Santana A
Gac Sanit; 2014; 28(1):77-83. PubMed ID: 23721868
[TBL] [Abstract][Full Text] [Related]
14. Systematic Review of Health State Utility Values Used in European Pharmacoeconomic Evaluations for Chronic Hepatitis C: Impact on Cost-Effectiveness Results.
Han R; François C; Toumi M
Appl Health Econ Health Policy; 2021 Jan; 19(1):29-44. PubMed ID: 32661846
[TBL] [Abstract][Full Text] [Related]
15. Preference-based quality of life of patients on renal replacement therapy: a systematic review and meta-analysis.
Liem YS; Bosch JL; Hunink MG
Value Health; 2008; 11(4):733-41. PubMed ID: 18194399
[TBL] [Abstract][Full Text] [Related]
16. The impact of age on health utility values for older women with early-stage breast cancer: a systematic review and meta-regression.
Wang Y; Gavan SP; Steinke D; Cheung KL; Chen LC
Health Qual Life Outcomes; 2022 Dec; 20(1):169. PubMed ID: 36564800
[TBL] [Abstract][Full Text] [Related]
17. Differences in utility elicitation methods in cardiovascular disease: a systematic review.
Blieden Betts M; Gandra SR; Cheng LI; Szatkowski A; Toth PP
J Med Econ; 2018 Jan; 21(1):74-84. PubMed ID: 28899233
[TBL] [Abstract][Full Text] [Related]
18. Systematic review of the impact of urinary tract infections on health-related quality of life.
Bermingham SL; Ashe JF
BJU Int; 2012 Dec; 110(11 Pt C):E830-6. PubMed ID: 22816657
[TBL] [Abstract][Full Text] [Related]
19. Ramucirumab for Treating Advanced Gastric Cancer or Gastro-Oesophageal Junction Adenocarcinoma Previously Treated with Chemotherapy: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Büyükkaramikli NC; Blommestein HM; Riemsma R; Armstrong N; Clay FJ; Ross J; Worthy G; Severens J; Kleijnen J; Al MJ
Pharmacoeconomics; 2017 Dec; 35(12):1211-1221. PubMed ID: 28656543
[TBL] [Abstract][Full Text] [Related]
20. Chained time trade-off and standard gamble methods. Applications in oesophageal cancer.
McNamee P; Glendinning S; Shenfine J; Steen N; Griffin SM; Bond J
Eur J Health Econ; 2004 Feb; 5(1):81-6. PubMed ID: 15452769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
